Clinical trials
Observational Drug Resistant Epilepsy trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
43 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 8 |
| 2023 | 1 |
| 2024 | 10 |
| 2025 | 1 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 12 |
| Completed | 9 |
| Recruiting | 8 |
| Not yet recruiting | 5 |
| Enrolling by invitation | 3 |
| Terminated | 3 |
| Active, not recruiting | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| LivaNova | 3 |
| Assiut University | 2 |
| University Hospital, Strasbourg, France | 2 |
| Xuanwu Hospital, Beijing | 2 |
| Acibadem University | 1 |
| Beijing Tiantan Hospital | 1 |
| CENTOGENE GmbH Rostock | 1 |
| Danone Nutricia SpA Società Benefit | 1 |
| Duke University | 1 |
| Firat University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Drug Resistant Epilepsy | 43 |
| Epilepsy | 17 |
| Epilepsies, Partial | 6 |
| Learning Disabilities | 2 |
| Obsessive-Compulsive Disorder | 2 |
| Seizures | 2 |
| Aneurysm | 1 |
| Arrhythmias, Cardiac | 1 |
| Arteriovenous Malformations | 1 |
| Autism Spectrum Disorder | 1 |
Trials
Showing 76 to 43 of 43. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.